Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Refractory Gout Is a Myth: Tips from an Expert

Samantha C. Shapiro, MD  |  July 22, 2022

At this EULAR 2022 session, one expert explains why he believes refractory gout is caused by mismanagement and discussed ways around treatment obstacles.

Filed under:ConditionsEULAR/OtherGout and Crystalline ArthritisMeeting Reports Tagged with:EULARGoutGout Resource Centerpatient carerefractory gout

Difficult-to-Treat Lupus: When & How to Use New Therapies

Samantha C. Shapiro, MD  |  July 21, 2022

Clinicians have numerous treatment options for SLE; in a EULAR 2022 session, some of the newer therapies were reviewed.

Filed under:ConditionsEULAR/OtherMeeting ReportsSystemic Lupus Erythematosus Tagged with:belimumabEULARHCQHydroxychloroquine (HCQ)rituximabSLEsystemic lupus erythematosus (SLE)

Biologic or Conventional Therapy for Early RA?

Michele B. Kaufman, PharmD, BCGP  |  July 19, 2022

A study has shown that in untreated patients with early RA, treatment with methotrexate combined with the biologic therapies abatacept or certolizumab-pegol resulted in greater CDAI remission rates than active conventional therapy with prednisolone, sulfasalazine or hydroxychloroquine.

Filed under:Biologics/DMARDsDrug UpdatesEULAR/OtherMeeting Reports Tagged with:Biologicsearly RAEULARRheumatoid Arthritis (RA)

Phase 2 Study Shows Promising Results for Deucravacitinib in PsA

Michele B. Kaufman, PharmD, BCGP  |  July 19, 2022

Research has demonstrated that deucravacitinib is significantly more efficacious than placebo for achieving minimal disease activity in patients with active PsA after 16 weeks of treatment.

Filed under:ConditionsDrug UpdatesEULAR/OtherMeeting ReportsPsoriatic Arthritis Tagged with:deucravacitinibEULARPsAPsoriatic Arthritistyrosine kinase 2 (TYK2)

Baricitinib Promising for Juvenile Idiopathic Arthritis

Michele B. Kaufman, PharmD, BCGP  |  July 19, 2022

In a study from Ramanan et al., baricitinib proved safe and effective for reducing the time to flare and frequency of flare in patients aged 2–18 years with juvenile idiopathic arthritis.

Filed under:ConditionsDrug UpdatesEULAR/OtherMeeting ReportsPediatric Conditions Tagged with:baricitinibEULARflareJIAjuvenile idiopathic arthritis (JIA)PediatricPediatric Rheumatology

Spine School: Axial Manifestations of Psoriatic Arthritis

Jason Liebowitz, MD, FACR  |  July 15, 2022

This EULAR 2022 session emphasized the importance of recognizing the axial manifestations of psoriatic arthritis and treating these symptoms accordingly.

Filed under:ConditionsEULAR/OtherMeeting ReportsPsoriatic Arthritis Tagged with:Axial Psoriatic Arthritis (axPsA)EULARPsAPsoriatic Arthritis

Study Compares Intra-Articular Morphine with Steroids & Placebo in Patients with Chronic Knee Arthritis

Michele B. Kaufman, PharmD, BCGP  |  July 15, 2022

A study from Haibel et al. in patients with chronic knee arthritis found intra-articular morphine did not lead to a significant, short-term reduction in pain compared with placebo and proved inferior to treatment with intra-articular triamcinolone.

Filed under:AnalgesicsConditionsDrug UpdatesOsteoarthritis and Bone DisordersPain Syndromes Tagged with:arthritis painChronic painmorphineosteoarthritis (OA)Pain Syndrome FocusRheumtriamcinolone acetonide

Never Too Late: Late-Breaking Abstracts Create Excitement

Jason Liebowitz, MD, FACR  |  July 15, 2022

EULAR 2022 (VIRTUAL)—The pace of scientific progress in research medicine is incredible and seems to only accelerate with time. Thus, the 2022 Congress of the European Alliance of Associations for Rheumatology (EULAR) session on late-breaking abstracts fittingly captured the excitement and timeliness of a number of research projects that have just recently been completed and…

Filed under:ConditionsEULAR/OtherMeeting Reports Tagged with:baricitinibBimekizumabdeucravacitinibEULARjuvenile idiopathic arthritis (JIA)MethotrexateorelabrutinibPolymyalgia RheumaticaPsoriatic Arthritissarilumabsystemic lupus erythematosus (SLE)

Clinical Guidance & Recommendation Updates for Vasculitis, axSpA & More

Jason Liebowitz, MD, FACR  |  July 15, 2022

In this EULAR 2022 session, new & revised treatment recommendations for ANCA-associated vasculitis, axial spondyloarthritis & rheumatoid arthritis were presented.

Filed under:Axial SpondyloarthritisConditionsEULAR/OtherMeeting ReportsRheumatoid ArthritisVasculitis Tagged with:AAV FocusRheumANCA-Associated Vasculitisanti-neutrophil cytoplasmic antibodies (ANCA)axial spondyloarthritis (SpA)eosinophilic granulomatosis with polyangiitis (EGPA)EULARmicroscopic polyangiitis (MPA)Rheumatoid Arthritis (RA)

Rheum After 5: Music, Medicine & Manure

Carol Patton  |  July 14, 2022

Elliot Rosenstein, MD, spends most weekend mornings and late afternoons a bit differently than other rheumatologists. He feeds and waters chickens, rabbits, llamas, horses, goats and guinea fowl, as well as an orphaned peacock. Dr. Rosenstein is one of two medical directors at the Institute of Rheumatic & Autoimmune Disease (IRAD) at Overlook Medical Center,…

Filed under:AudioProfilesRheum After 5 Tagged with:Dr. Elliot Rosenstein

  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences